Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Loffredo

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Urology|November 16, 2005
Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancerTomas Dvorak, Ming-Hui Chen, Andrew A Renshaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk diseaseAnthony V D'Amico, Andrew A Renshaw, Kerri Cote, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2006
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancerClair Beard, Delray Schultz, Marian Loffredo, et al.
Cancer|June 26, 2013
Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trialMiranda B Kim, Ming-Hui Chen, Mário de Castro, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendationsPaul L Nguyen, Ming-Hui Chen, Andrew A Renshaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized TrialNicholas J Giacalone, Jing Wu, Ming-Hui Chen, et al.
Urologic Oncology|July 24, 2004
Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapyMona V Sanghani, Jane Ching, Delray Schultz, et al.
JAMA Oncology|January 19, 2017
Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical TrialTrevor J Royce, Ming-Hui Chen, Jing Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen eraAnthony V D'Amico, Ming-Hui Chen, Jean Oh-Ung, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilizationRosemonde Woel, Clair Beard, Ming-Hui Chen, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Urology|November 16, 2005
Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancerTomas Dvorak, Ming-Hui Chen, Andrew A Renshaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk diseaseAnthony V D'Amico, Andrew A Renshaw, Kerri Cote, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2006
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancerClair Beard, Delray Schultz, Marian Loffredo, et al.
Cancer|June 26, 2013
Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trialMiranda B Kim, Ming-Hui Chen, Mário de Castro, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendationsPaul L Nguyen, Ming-Hui Chen, Andrew A Renshaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized TrialNicholas J Giacalone, Jing Wu, Ming-Hui Chen, et al.
Urologic Oncology|July 24, 2004
Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapyMona V Sanghani, Jane Ching, Delray Schultz, et al.
JAMA Oncology|January 19, 2017
Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical TrialTrevor J Royce, Ming-Hui Chen, Jing Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen eraAnthony V D'Amico, Ming-Hui Chen, Jean Oh-Ung, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilizationRosemonde Woel, Clair Beard, Ming-Hui Chen, et al.
Pageof 6